Ljupka Dimitrovska

Dr. Ljupka Dimitrovska

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Cardiologia Croatica
Verified
Journal Article
Closed access
LDLjupka Dimitrovska
Ljupka Dimitrovska
JDJure Dolenc
Jure Dolenc
MJMatija Jelenc
Matija Jelenc
ZDZvezdana Dolenc-Stražar
Zvezdana Dolenc-Stražar
TKTomislav Klokočovnik
Tomislav Klokočovnik

1 April 2017 in Cardiologia Croatica
Verified
Journal Article
Closed access
LDLjupka Dimitrovska
Ljupka Dimitrovska
UKUrška Dolores Breskvar Kač
Urška Dolores Breskvar Kač
JAJana Ambrozic
Jana Ambrozic
MBMojca Bervar
Mojca Bervar

1 April 2017 in Cardiologia Croatica
Verified
Journal Article
Closed access
UKUrška Dolores Breskvar Kač
Urška Dolores Breskvar Kač
LDLjupka Dimitrovska
Ljupka Dimitrovska
JAJana Ambrozic
Jana Ambrozic
MBMojca Bervar
Mojca Bervar

1 April 2019 in Cardiologia Croatica
Verified
Journal Article
Closed access
LDLjupka Dimitrovska
Ljupka Dimitrovska
BABor Antolič
Bor Antolič
RZRok Zbačnik
Rok Zbačnik
MŠMatjaž Šinkovec
Matjaž Šinkovec
JAJana Ambrozic
Jana Ambrozic

Verified
Journal Article
Open access
PDF file
JAJana Ambrozic
Jana Ambrozic
DPDušica Prodanova
Dušica Prodanova
ASAna Starc
Ana Starc
Mojca ŠkafarMojca Škafar
Mojca Škafar
LDLjupka Dimitrovska
Ljupka Dimitrovska
MCMarta Cvijić
Marta Cvijić
Objectives: Quantifying ventricular secondary mitral regurgitation (MR) remains challenging, and the prognostic value of echocardiographic parameters is uncertain. This study aimed to assess the concordance of parameters of MR severity and determine the added value of regurgitant fraction (RF) in predicting outcomes. Methods and results: We retrospectively analysed 186 patients with ventricular secondary MR who underwent echocardiography with MR assessment, evaluating effective regurgitant orifice area (EROA), regurgitant volume (RegVol) and RF. The primary endpoint was a composite of all-cause death or heart failure hospitalisation. Quantitative parameters of MR severity were frequently discordant. Using the guideline-recommended cut-offs for EROA (≥40 mm2), RegVol (≥60 mL) and RF (≥50%), severe MR was present in 5.4%, 3.3%, and 29.5% of patients, respectively. Both RF ≥ 50% and EROA ≥ 40 mm2 were independently associated with clinical outcomes in multivariable Cox models. Combining RF and EROA provided incremental prognostic value over either parameter alone (p < 0.05). Kaplan–Meier curves showed that patients with EROA < 40 mm2 and RF ≥ 50% had similar outcomes to those with EROA ≥ 40 mm2 (p = 0.055), whereas patients with both EROA < 40 mm2 and RF < 50% had significantly better outcomes (p = 0.002). Conclusions: Substantial discordance between quantitative parameters of severe MR was observed in ventricular secondary MR. RF is a strong, underutilised marker of MR severity, reflecting haemodynamic burden beyond EROA and RegVol. Patients with EROA < 40 mm2 and RF > 50% had outcomes comparable to those who met the guideline-based threshold for severe MR, defined as EROA ≥ 40 mm2. Our results demonstrate that routine RF assessment may enhance risk stratification and enable identification of a high-risk subgroup of patients with EROA < 40 mm2.

25 March 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
JAJana Ambrozic
Jana Ambrozic
DPDušica Prodanova
Dušica Prodanova
ASAna Starc
Ana Starc
Mojca ŠkafarMojca Škafar
Mojca Škafar
LDLjupka Dimitrovska
Ljupka Dimitrovska
MCMarta Cvijić
Marta Cvijić

Objectives: Quantifying ventricular secondary mitral regurgitation (MR) remains challenging, and the prognostic value of echocardiographic parameters is uncertain. This study aimed to assess the concordance of parameters of MR severity and determine the added value of regurgitant fraction (RF) in predicting outcomes. Methods and results: We retrospectively analysed 186 patients with ventricular secondary MR who underwent echocardiography with MR assessment, evaluating effective regurgitant orifice area (EROA), regurgitant volume (RegVol) and RF. The primary endpoint was a composite of all-cause death or heart failure hospitalisation. Quantitative parameters of MR severity were frequently discordant. Using the guideline-recommended cut-offs for EROA (≥ 40 mm2), RegVol (≥ 60 ml) and RF (≥ 50%), severe MR was present in 5.4%, 3.3%, and 29.5% of patients, respectively. Both RF ≥ 50% and EROA ≥ 40 mm² were independently associated with clinical outcomes in multivariable Cox models. Combining RF and EROA provided incremental prognostic value over either parameter alone (p < 0.05). Kaplan-Meier curves showed that patients with EROA < 40 mm² and RF ≥ 50% had similar outcomes to those with EROA ≥ 40 mm² (p = 0.055), whereas patients with both EROA < 40 mm² and RF < 50% had significantly better outcomes (p = 0.002). Conclusions: Substantial discordance between quantitative parameters of severe MR was observed in ventricular secondary MR. RF is a strong, underutilised marker of MR severity, reflecting haemodynamic burden beyond EROA and RegVol. Patients with EROA < 40 mm2 and RF > 50% had outcomes comparable to those who met guideline-based threshold for severe MR, defined as EROA ≥ 40 mm2. Our results demonstrate that routine RF assessment enhances risk stratification and enables identification of a high-risk subgroup of patients with EROA < 40 mm2.